83 Alternatively, combining anti-CD73 antibodies with OVs may improve treatment outcomes. 82,85 Could the inhibition of CD73 be feasible with an OVT in a cis or trans approach to enhance host immune responses to a tumour, thus turning it from 'turning up the heat' from 'cold to hot'? The gene discussed is NT5E; the disease is neoplasm.